Acute Salt Handling in Orthostatic Intolerance
NCT00581633 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-10-06
Summary
The investigators will test the hypothesis that patients with chronic orthostatic intolerance or postural orthostatic tachycardia syndrome (OI or POTS) will be unable to conserve urinary sodium as compared to healthy control subjects.
Conditions
- Postural Tachycardia Syndrome
- Orthostatic Tachycardia
- Orthostatic Intolerance
Interventions
- OTHER
-
normal saline (0.9%)
liter normal saline over 30 minutes x 1 dose
Sponsors & Collaborators
-
National Center for Research Resources (NCRR)
collaborator NIH -
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Vanderbilt University
lead OTHER
Principal Investigators
-
Satish R Raj, MD MSCI · Vanderbilt University Medical Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2029-12-31
- Completion
- 2029-12-31
Countries
- United States
Study Locations
More Related Trials
-
Diagnosing Natriuretic Peptide Deficiency
NCT03035929 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure
NCT00348556 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Role of Mineralocorticoid Receptors in Vascular Function
NCT00759525 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Nesiritide and Renal Function After the Total Artificial Heart
NCT01836809 ·Status: TERMINATED ·Phase: PHASE4
-
Relation Between COVID-19 Pts and Hyponatremia in Adreno Ortical Insufficient Patients.
NCT05408481 ·Status: UNKNOWN
-
Spironolactone in CKD Enabled by Chlorthalidone: PILOT
NCT05222191 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Amiloride and Spironolactone in Healthy Persons
NCT00857909 ·Status: COMPLETED ·Phase: PHASE1
-
Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.
NCT00405548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Phenotyping of Autonomous Aldosterone Secretion
NCT03484130 ·Status: ACTIVE_NOT_RECRUITING
-
Tissue Sodium in Pre-hypertensive Patients
NCT02236520 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension
NCT00237783 ·Status: TERMINATED ·Phase: PHASE1
-
Concentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney Dysfunction
NCT00575484 ·Status: TERMINATED ·Phase: PHASE2
-
Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN
NCT03683069 ·Status: COMPLETED ·Phase: PHASE4
-
Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
NCT00170183 ·Status: COMPLETED ·Phase: PHASE3
-
Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease
NCT03141905 ·Status: COMPLETED ·Phase: NA
-
Saline Infusion Test in Hyponatremia
NCT06498856 ·Status: NOT_YET_RECRUITING
-
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia
NCT00660959 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD
NCT01750294 ·Status: COMPLETED ·Phase: PHASE4
-
Spironolactone Safety in Dialysis Patients
NCT00328809 ·Status: WITHDRAWN ·Phase: PHASE4
-
Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction
NCT00119691 ·Status: COMPLETED ·Phase: PHASE2
-
Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00380575 ·Status: COMPLETED ·Phase: PHASE3
-
Measurement of Sweat Sodium Concentration in Patients With Chronic Kidney Disease
NCT06354842 ·Status: COMPLETED
-
The Role of Vasopressin Antagonism on Renal Sodium Handling
NCT03910231 ·Status: COMPLETED ·Phase: PHASE1
-
Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration
NCT05190744 ·Status: COMPLETED ·Phase: PHASE2
-
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
NCT01056848 ·Status: COMPLETED